97 related articles for article (PubMed ID: 19742363)
1. Brief research report: uncertainty-inducing and reassuring facts about HPV: a descriptive study of French Canadian women.
Rosen NO; Knäuper B; Pagé G; Di Dio P; Morrison E; Mayrand MH; Franco EL; Rosberger Z
Health Care Women Int; 2009 Oct; 30(10):892-902. PubMed ID: 19742363
[TBL] [Abstract][Full Text] [Related]
2. Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening.
Papa D; Moore Simas TA; Reynolds M; Melnitsky H
J Low Genit Tract Dis; 2009 Apr; 13(2):66-71. PubMed ID: 19387125
[TBL] [Abstract][Full Text] [Related]
3. Do cervical cancer screening patient information leaflets meet the HPV information needs of women?
Hall B; Howard K; McCaffery K
Patient Educ Couns; 2008 Jul; 72(1):78-87. PubMed ID: 18372144
[TBL] [Abstract][Full Text] [Related]
4. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
McCaffery K; Irwig L
J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
[TBL] [Abstract][Full Text] [Related]
5. Balancing uncertainty and acceptance: understanding Chinese women's responses to an abnormal cervical smear result.
Twinn S
J Clin Nurs; 2006 Sep; 15(9):1140-8. PubMed ID: 16911055
[TBL] [Abstract][Full Text] [Related]
6. Informational needs and the experiences of women with abnormal Papanicolaou smears.
Bertram CC; Magnussen L
J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
[TBL] [Abstract][Full Text] [Related]
7. HPV vaccination: vaccine acceptance, side effects and screening intentions.
Paul-Ebhohimhen V; Huc S; Tissington H; Oates K; Stark C
Community Pract; 2010 Jun; 83(6):30-3. PubMed ID: 20586376
[TBL] [Abstract][Full Text] [Related]
8. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
Cibas ES; Hong X; Crum CP; Feldman S
Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
[TBL] [Abstract][Full Text] [Related]
9. The human papillomavirus in women over 40: implications for practice and recommendations for screening.
Montgomery K; Bloch JR
J Am Acad Nurse Pract; 2010 Feb; 22(2):92-100. PubMed ID: 20132367
[TBL] [Abstract][Full Text] [Related]
10. The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: a randomised controlled study.
Rosen NO; Knäuper B; Di Dio P; Morrison E; Tabing R; Feldstain A; Amsel R; Mayrand MH; Franco EL; Rosberger Z
Psychol Health; 2010 Jul; 25(6):651-68. PubMed ID: 20204959
[TBL] [Abstract][Full Text] [Related]
11. Preferences for sources of information about abnormal Pap tests and HPV in women tested for HPV.
McCree DH; Sharpe PA; Brandt HM; Robertson R
Prev Med; 2006 Sep; 43(3):165-70. PubMed ID: 16701815
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
14. Informed consent? How do primary care professionals prepare women for cervical smears: a qualitative study.
Chew-Graham C; Mole E; Evans LJ; Rogers A
Patient Educ Couns; 2006 Jun; 61(3):381-8. PubMed ID: 15964735
[TBL] [Abstract][Full Text] [Related]
15. HPV presence precedes abnormal cytology in women developing cervical cancer and signals false negative smears.
Zielinski GD; Snijders PJ; Rozendaal L; Voorhorst FJ; van der Linden HC; Runsink AP; de Schipper FA; Meijer CJ
Br J Cancer; 2001 Aug; 85(3):398-404. PubMed ID: 11487272
[TBL] [Abstract][Full Text] [Related]
16. Women's experiences of repeated HPV testing in the context of cervical cancer screening: a qualitative study.
Waller J; McCaffery K; Kitchener H; Nazroo J; Wardle J
Psychooncology; 2007 Mar; 16(3):196-204. PubMed ID: 16858719
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus testing for primary cervical cancer screening.
Grce M; Davies P
Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808
[TBL] [Abstract][Full Text] [Related]
19. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London.
Szarewski A; Cadman L; Ashdown-Barr L; Waller J
J Med Screen; 2009; 16(4):193-8. PubMed ID: 20054094
[TBL] [Abstract][Full Text] [Related]
20. Introducing HPV triage into the English cervical cancer screening program: consequences for participation.
Philips Z; Avis M; Whynes DK
Women Health; 2006; 43(2):17-34. PubMed ID: 17000609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
